SPX-101

N/A

Report date: 2024/06/20 20:00:09
NME

Base Information

Drug NameSPX-101
Drug Alias NameSPX-101
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionEpithelial sodium channel blockers
TargetsEpithelial sodium channel
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaPortugalItaly +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSpyryx Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpyryx Biosciences Inc
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A